---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-034200"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2022-12-01T23:59:59+00:00"
generated_at: "2026-06-21T10:46:19.808609+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# TRxADE HEALTH gets Nasdaq non-compliance notice for minimum bid price; also fails equity requirement

## Summary
- Received Nasdaq notice Nov 29, 2022 for bid price below $1.00 for 30 consecutive business days through Nov 28, 2022.
- Has 180 days until May 29, 2023 to regain compliance by closing at $1.00 for 10 consecutive business days.
- Also not in compliance with $2.5M minimum stockholders' equity requirement; must complete transactions by Jan 25, 2023.
- To satisfy equity rule, company completed $1.75M stock sale Oct 7, 2022; must evidence compliance by Jan 25 deadline.

## SEC filing metadata
- accession: 0001493152-22-034200
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2022-12-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000149315222034200/0001493152-22-034200-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000149315222034200/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-034200
- JSON: https://secwatch.observer/filing/0001493152-22-034200.json
- Plain text: https://secwatch.observer/filing/0001493152-22-034200.txt

## Key facts
- Listing & Compliance Notices
  Scienture Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: November 29, 2022, TRxADE HEALTH, Inc. (the “ Company ”, “ we ” or “ us ”) received written notice (the “ Notification Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price re
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315222034200/0001493152-22-034200-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.